Richard M. Sherry
- Oncology top 0.02%
- Immunology top 0.05%
- Molecular Biology top 0.5%
- Genetics top 0.2%
- Pulmonary and Respiratory Medicine top 0.5%
- Co-authors
- Steven A. RosenbergJames Chih‐Hsin YangSuzanne L. TopalianUdai S. KammulaMarybeth S. HughesNicholas P. RestifoMark E. DudleyDonald E. White
- Topics
- Immunotherapy and Immune Responses (50 papers)CAR-T cell therapy research (46 papers)Cancer Immunotherapy and Biomarkers (36 papers)
- Cited by
- OncologyImmunologyGenetics
- Partner nations
- United StatesAustraliaMalaysia
In The Last Decade
Richard M. Sherry
97 papers receiving 24.5k citations
Hit Papers
Peers
Comparison fields: 5 of 139
- Oncology 18.5k
- Immunology 13.8k
- Molecular Biology 6.1k
- Genetics 3.8k
- Pulmonary and Respiratory Medicine 2.8k
Countries citing papers authored by Richard M. Sherry
This map shows the geographic impact of Richard M. Sherry's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Richard M. Sherry with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Richard M. Sherry more than expected).
Fields of papers citing papers by Richard M. Sherry
This network shows the impact of papers produced by Richard M. Sherry. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Richard M. Sherry. The network helps show where Richard M. Sherry may publish in the future.
Co-authorship network of co-authors of Richard M. Sherry
This figure shows the co-authorship network connecting the top 25 collaborators of Richard M. Sherry. A scholar is included among the top collaborators of Richard M. Sherry based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Richard M. Sherry. Richard M. Sherry is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 72 | |
| 2 | 204 | |
| 3 | 77 | |
| 4 | Complete Regression of Metastatic Cervical Cancer After Treatment With Human Papillomavirus–Targeted Tumor-Infiltrating T Cellsbreakdown → | 506 |
| 5 | 332 | |
| 6 | 39 | |
| 7 | A Pilot Trial Using Lymphocytes Genetically Engineered with an NY-ESO-1–Reactive T-cell Receptor: Long-term Follow-up and Correlates with Responsebreakdown → | 585 |
| 8 | 369 | |
| 9 | Durable Complete Responses in Heavily Pretreated Patients with Metastatic Melanoma Using T-Cell Transfer Immunotherapybreakdown → | 1603 |
| 10 | 16 | |
| 11 | 245 | |
| 12 | Adoptive Cell Therapy for Patients With Metastatic Melanoma: Evaluation of Intensive Myeloablative Chemoradiation Preparative Regimensbreakdown → | 1017 |
| 13 | Cancer Regression in Patients After Transfer of Genetically Engineered Lymphocytesbreakdown → | 1961 |
| 14 | Enterocolitis in Patients With Cancer After Antibody Blockade of Cytotoxic T-Lymphocyte–Associated Antigen 4breakdown → | 646 |
| 15 | 28 | |
| 16 | 365 | |
| 17 | Cancer regression and autoimmunity induced by cytotoxic T lymphocyte-associated antigen 4 blockade in patients with metastatic melanomabreakdown → | 1234 |
| 18 | 91 | |
| 19 | Phase I Study of the Intravenous Administration of AttenuatedSalmonella typhimuriumto Patients With Metastatic Melanomabreakdown → | 565 |
| 20 | Embolization of a hepatoportal fistula in a patient with Ehlers-Danlos syndrome and colon perforation. | 19 |
About Richard M. Sherry
Richard M. Sherry is a scholar working on Immunology, Oncology and Genetics, having authored 97 papers that have together received 25.0k indexed citations. Recurring topics across this work include Immunotherapy and Immune Responses (50 papers), CAR-T cell therapy research (46 papers) and Cancer Immunotherapy and Biomarkers (36 papers). The work is most often cited by research in Oncology (18.5k citations), Immunology (13.8k citations) and Genetics (3.8k citations). Richard M. Sherry has collaborated with scholars based in United States, Australia and Malaysia. Frequent co-authors include Steven A. Rosenberg, James Chih‐Hsin Yang, Suzanne L. Topalian, Udai S. Kammula, Marybeth S. Hughes, Nicholas P. Restifo, Mark E. Dudley, Donald E. White, Seth M. Steinberg and John R. Wunderlich. Their work appears in journals such as Science, New England Journal of Medicine and Proceedings of the National Academy of Sciences.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.